Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025)

Benitec Biopharma has reported Other Non-Current Assets for 7 years, with the latest figure at $11000.0 in Q4 2025.

• Quarterly Other Non-Current Assets fell 56.0% year-over-year to $11000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11000.0 (down 56.0% YoY) and the FY2025 annual result came in at $28000.0, up 12.0% from the prior year.
• Other Non-Current Assets declined to $11000.0 in Q4 2025 per BNTC's latest filing, from $500000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $984000.0 in Q2 2021 and troughed at $9000.0 in Q1 2021.
• A 5-year average of $188052.6 and a median of $97000.0 in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets soared 10833.33% in 2021, then sank 86.28% in 2022.
• Over 5 years, Other Non-Current Assets stood at $161000.0 in 2021, then retreated by 27.95% to $116000.0 in 2022, then sank by 30.17% to $81000.0 in 2023, then tumbled by 69.14% to $25000.0 in 2024, then tumbled by 56.0% to $11000.0 in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $11000.0, $500000.0, and $28000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.